All Stories

  1. Non-neoplastic bulky mediastinal mass presentation in an adolescent patient: a case report

    Article • Journal of Medical Case Reports, October 2013, Springer Science + Business Media

    Dr Israel Bendit

  2. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays

    Article • Drug Design Development and Therapy, August 2013, Taylor & Francis

    Dr Israel Bendit

  3. Atualização em leucemia mieloide crônica

    Article • Revista da Associação Médica Brasileira, July 2013, Elsevier

    Dr Israel Bendit

  4. Update on chronic myeloid leukemia

    Article • Revista da Associação Médica Brasileira (English Edition), January 2013, Elsevier

    Dr Israel Bendit

  5. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations

    Article • Journal of Pediatric Surgery, March 2012, Elsevier

    Dr Israel Bendit

  6. Pretherapeutic Expression of the <i>hOCT1</i> Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia

    Article • Acta Haematologica, January 2012, Karger Publishers

    Dr Israel Bendit

  7. Simultaneous Occurrence of Biphenotypic T Cell/Myeloid Lesions Involving t(12;13)(p13;q14) in a Pediatric Patient

    Article • Acta Haematologica, January 2012, Karger Publishers

    Dr Israel Bendit

  8. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute

    Article • Acta Haematologica, January 2012, Karger Publishers

    Dr Israel Bendit

  9. Dasatinib Overrides Imatinib Resistance Mediated by the F359I Residue Mutation in Two Patients with Chronic Myeloid Leukemia

    Article • Acta Haematologica, November 2011, Karger Publishers

    Dr Israel Bendit

  10. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma

    Article • Pediatric Blood & Cancer, December 2010, Wiley

    Dr Israel Bendit

  11. Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study

    Article • Clinical Medicine Insights Oncology, December 2010, Libertas Academica, Ltd.

    Dr Israel Bendit

  12. Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib Therapy

    Article • Clinical Medicine Insights Oncology, December 2010, Libertas Academica, Ltd.

    Dr Israel Bendit

  13. Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission

    Article • BMC Hematology, November 2010, Springer Science + Business Media

    Dr Israel Bendit

  14. Current patient management of chronic myeloid leukemia in Latin America

    Article • Cancer, July 2010, Wiley

    Dr Israel Bendit

  15. Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia

    Article • Acta Haematologica, January 2010, Karger Publishers

    Dr Israel Bendit

  16. Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy

    Article • Advances in Hematology, January 2010, Hindawi Publishing Corporation

    Dr Israel Bendit

  17. Efeitos adversos e resposta citogenética em pacientes com leucemia mieloide crônica tratados com imatinibe

    Article • Revista Brasileira de Hematologia e Hemoterapia, January 2010, Elsevier

    Dr Israel Bendit

  18. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study

    Article • Journal of Hematology & Oncology, October 2009, Springer Science + Business Media

    Dr Israel Bendit

  19. The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

    Article • Journal of Transplantation, January 2009, Hindawi Publishing Corporation

    Dr Israel Bendit

  20. Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors

    Article • International Journal of Hematology, December 2008, Springer Science + Business Media

    Dr Israel Bendit

  21. Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia

    Article • International Journal of Hematology, July 2008, Springer Science + Business Media

    Dr Israel Bendit

  22. Monitoração molecular da Leucemia Mielóide Crônica na era do imatinibe

    Article • Revista Brasileira de Hematologia e Hemoterapia, April 2008, Elsevier

    Dr Israel Bendit

  23. Complete response to imatinib mesylate treatment in a 12‐month‐old patient with chronic myeloid leukemia

    Article • Pediatric Blood & Cancer, December 2007, Wiley

    Dr Israel Bendit

  24. Ethnic Differences in Cerebral Venous Thrombosis

    Article • Cerebrovascular Diseases, January 2005, Karger Publishers

    Dr Israel Bendit

  25. Mdm2 mRNA expression in salivary gland tumour cell lines

    Article • Journal of Oral Pathology and Medicine, January 2004, Wiley

    Dr Israel Bendit, Professor Fabio Daumas Nunes

  26. Peripheral Blood c-erbB-2 Expression by Reverse Transcriptase—Polymerase Chain Reaction in Breast Cancer Patients Receiving Chemotherapy

    Article • Clinical Breast Cancer, August 2002, Elsevier

    Dr Israel Bendit

  27. Growth Hormone and Insulin-like Growth Factor I Axis and Growth of Children With Different Sickle Cell Anemia Haplotypes

    Article • Journal of Pediatric Hematology/Oncology, August 2001, Wolters Kluwer Health

    Dr Israel Bendit

  28. Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia

    Article • Leukemia Research, August 2001, Elsevier

    Dr Israel Bendit

  29. CK-19 Expression by RT-PCR in the Peripheral Blood of Breast Cancer Patients Correlates with Response to Chemotherapy

    Article • Breast Cancer Research and Treatment, April 2001, Springer Science + Business Media

    Dr Israel Bendit

  30. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia

    Article • Leukemia Research, November 1998, Elsevier

    Dr Israel Bendit

  31. Concomitant p53 mutation and MYCN amplification in neuroblastoma

    Article • Medical and Pediatric Oncology, September 1997, Wiley

    Dr Israel Bendit

  32. Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformation

    Article • Cancer Genetics and Cytogenetics, October 1995, Elsevier

    Dr Israel Bendit

  33. N-myc Oncogene Expression in Porcine Renal Development and Oncogenesis

    Article • Pediatric Research, March 1991, Springer Science + Business Media

    Dr Israel Bendit

  34. Molecular phenotype of a pediatric small round cell tumor

    Article • Cancer, October 1990, Wiley

    Dr Israel Bendit

  35. N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma

    Article • Cancer, June 1990, Wiley

    Dr Israel Bendit